510(k) · Cleared
ClearedProcellera
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Vomaris Innovations, Inc. · FRO Dressing, Wound, Drug
Cleared on Jul 2, 2013 as substantially equivalent to K081977 (Silverleaf Medical Products, Inc., 2008) and 1 other predicate after a 140-day review. Its family tree reaches back 4 generations to 1992. 2 later devices descend from it.
- Decided
- Jul 2, 2013
- Review
- 140 days
- Class
- Class U
- Product code
- FRO
- Recalls
- None
- Predicates
- 2
Its longest line of descent runs back 4 generations to K914579 (1992). 8 ancestors in all. 2 later devices descend from it, 2 citing it directly.
- Root · 4 generations backK914579 Silver Foam Wound DressingVitaphore Corp. · 1992
- 3 generations backK955453 Acticoat Silver Coated DressingWestaim Technologies, Inc. · 1996
- 2 generations backK060237 CMB Antimicrobial DressingSilverleaf Medical Products, Inc. · 2006
- 1 generation backK081977 Prosit Wound Treatment DeviceSilverleaf Medical Products, Inc. · 2008
- This deviceK130350 ProcelleraVomaris Innovations, Inc. · 2013
- Descendant · cites it directly · 1 of its ownK160783 ProcelleraVomaris Innovations, Inc. · 2016
- Descendant · cites it directly · 0 of its ownK180533 Procellera Composite Antibacterial Wound DressingVomaris Wound Care, Inc. · 2018
Most influential descendants
Showing 2 of 2 · See allView FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −4 | K914579 | Silver Foam Wound Dressing | Vitaphore Corp. | 1992 | — |
| −3 | K955453 | Acticoat Silver Coated Dressing | Westaim Technologies, Inc. | 1996 | — |
| −2 | K060237 | CMB Antimicrobial Dressing | Silverleaf Medical Products, Inc. | 2006 | — |
| −1 | K081977 | Prosit Wound Treatment Device | Silverleaf Medical Products, Inc. | 2008 | — |
| 0 (this device) | K130350 | Procellera | Vomaris Innovations, Inc. | 2013 | — |
| +1 | K160783 | Procellera | Vomaris Innovations, Inc. | 2016 | — |
| +1 | K180533 | Procellera Composite Antibacterial Wound Dressing | Vomaris Wound Care, Inc. | 2018 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1995 | 1 | 0 |
| 1997 | 2 | 0 |
| 2004 | 1 | 0 |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2016 | 1 | 0 |
| 2018 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in FRO? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new FRO device
- #1 K261023 Microdacyn Wound Irrigation Solutionscore 15.5 · 14 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (2)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K081977 | Prosit Wound Treatment DeviceSummary page 2…Phone: 480-921-4948 Fax: 480-921-0948 Technological Characteristics: Procellera® device is identical to the device cleared under 5 10(k) K060237 and K08 1977. Elemental silver and elemental zinc are bound to the surface of a polyester substrate in a well-characterized dot matrix pattern… | 2008 |
| * | K060237 | CMB Antimicrobial DressingSummary page 1…lera® Wound Dressing Trade Name: Procellera®) Common Name: Wound Dressing Product Code: FRO Predicate Devices: Procellera®0 wound dressing (KOS 1977) CMBTM dressing (K060237) Device Description: Procellera® is a single layer dressing; it consists of a polyester substrate containing elemental silver… | 2006 |
What descends from it? (2)
2 later devices cite it directly; ranked here by how many devices descend from each in turn.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 21 years and passes through 4 companies; a new generation was cleared every 4.6 years on median.
- 1 of the 8 ancestors has a recall of any class.
- Of its descendants, K160783 (Vomaris Innovations, Inc., 2016) has gone furthest, with 1 descendant of its own.
- 2 other devices also cite its predicate K081977.
How does its category compare?
All FRO devicesFRO Dressing, Wound, Drug: FDA decisions, review times, recalls and adverse event reports over 20 years. 2013, this device’s year, is highlighted.
FDA decisions per year · FRO
11in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · FRO
176in 2025
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · FRO
2in 2024
Class I (2 since 2007) Class II/III not classified
Adverse event reports per year · FRO
192in 2025
MAUDE reports naming product code FRO, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 29 | 187 | 4 | 55 |
| 2008 | 26 | 130 | 1 | 30 |
| 2009 | 31 | 136 | 1 | 45 |
| 2010 | 31 | 146 | 0 | 122 |
| 2011 | 27 | 177 | 4 | 42 |
| 2012 | 24 | 96 | 0 | 65 |
| 2013 | 19 | 194 | 1 | 139 |
| 2014 | 22 | 214 | 1 | 269 |
| 2015 | 28 | 249 | 2 | 297 |
| 2016 | 28 | 222 | 3 | 147 |
| 2017 | 23 | 147 | 1 | 149 |
| 2018 | 20 | 206 | 0 | 128 |
| 2019 | 16 | 270 | 1 | 136 |
| 2020 | 12 | 226 | 0 | 139 |
| 2021 | 8 | 275 | 6 | 183 |
| 2022 | 9 | 332 | 2 | 176 |
| 2023 | 18 | 283 | 2 (2) | 198 |
| 2024 | 24 | 263 | 2 | 232 |
| 2025 | 11 | 176 | 0 | 192 |
| 2026 | 17 | 254 | 2 | — |
What is it indicated for?
For prescription use, Procellera® antimicrobial wound dressing is intended for the management of wounds to provide a moist wound environment and is indicated for partial and full-thickness wounds such as pressure ulcers, venous ulcers, diabetic ulcers, first and second degree burns, surgical incisions, donor and/or recipient graft sites, etc.
For over-the-counter use, Procellera® wound dressing is intended for the management of wounds to provide a moist wound environment and is indicated for superficial wounds such as minor cuts, scrapes, irritations, abrasions, blisters, etc.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K130350 · printed Nov 4, 2026
Cite this page
510(k) Report. “K130350: Procellera.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K130350
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026